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Background: Symptomatic heart failure (HF) and reduced left ventricular ejection fraction (EF) are both associated with increased short-term 
mortality in patients with non–ST-segment elevation myocardial infarction (NSTEMI), but long-term outcomes associated with the development of 
clinical HF in patients with and without a reduced EF are uncertain.
methods: We analyzed a total of 26,291 NSTEMI patients ≥65 years in the CRUSADE Registry with linked CMS longitudinal data who survived to 
hospital discharge and had a measured EF. We described in-hospital treatment differences and 1-year outcomes among patients stratified by the 
development of symptomatic HF and measured EF values (≥40 and <40%).
results: Significant differences in patient characteristics, in-hospital procedures, hospital readmission, and 1-year mortality rates were observed in 
patients stratified by EF and the development of symptomatic HF (Table). Compared with patients without HF and an EF ≥40%, the adjusted 1-year 
mortality risks were higher among patients with EF <40% without HF (hazard ratio [HR] 1.82: 95% confidence interval [CI], 1.65–2.00), with an EF 
≥40% and HF (HR 1.81: 95% CI, 1.66–1.98), and with EF <40% with HF (HR 2.29: 95% CI, 2.06–2.53).
conclusions: The development of symptomatic HF and reduced EF are both associated with an increased risk of long-term hospital re-admission 
and mortality in NSTEMI patients. These data provide opportunities for more aggressive secondary prevention in this high-risk population. 
